Eqis Capital Management, Inc. Lannett CO Inc Transaction History

Eqis Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$6.43 - $9.86 $198,217 - $303,954	-30,827 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$6.36 - $10.05 $7,574 - $11,969	1,191 Added 4.02%	30,827 $279,000
Q4 2019 Jan 24, 2020	BUY	$8.49 - $12.81 $24,884 - $37,546	2,931 Added 10.98%	29,636 $261,000
Q3 2019 Nov 05, 2019	BUY	$5.58 - $14.47 $149,013 - $386,421	26,705 New	26,705 $299,000
Q2 2019 Jul 18, 2019	SELL	$5.22 - $9.08 $197,785 - $344,041	-37,890 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$5.35 - $9.82 $158,408 - $290,760	-29,609 Reduced 43.87%	37,890 $298,000
Q4 2018 Jan 25, 2019	SELL	$3.43 - $6.19 $47,851 - $86,356	-13,951 Reduced 17.13%	67,499 $335,000
Q3 2018 Oct 17, 2018	BUY	$4.75 - $14.5 $262,670 - $801,835	55,299 Added 211.46%	81,450 $452,000
Q2 2018 Jul 27, 2018	BUY	$13.3 - $17.45 $347,808 - $456,334	26,151 New	26,151 $356,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.